Immune markers are predictive of CMV infection in seropositive lung transplant recipients

被引：0
|
作者：
Gardiner, Bradley [1 ,2 ]
Lee, Sue [1 ]
Robertson, Allisa N. [1 ]
Snell, Gregory I. [2 ,3 ]
Westall, Glen P. [2 ,3 ]
Peleg, Anton Y. [1 ,2 ]
机构：
[1] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[2] Alfred Hlth, Dept Resp Med, Lung Transplant Serv, Melbourne, Vic, Australia
[3] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
222.6
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [41] Cytomegalovirus Antibody Titers Correlate With the Risk of CMV Reactivation in CMV-Seropositive Liver Transplant Recipients
    Bruminhent, J.
    Thongprayoon, C.
    Razonable, R.
    TRANSPLANTATION, 2014, 98 : 179 - 179
  • [42] Association of CMV-specific T-cell immunity and risk of CMV infection in lung transplant recipients
    Veit, Tobias
    Pan, Ming
    Munker, Dieter
    Arnold, Paola
    Dick, Andrea
    Kunze, Susanne
    Meiser, Bruno
    Schneider, Christian
    Michel, Sebastian
    Zoller, Michael
    Boehm, Stephan
    Walter, Julia
    Behr, Juergen
    Kneidinger, Nikolaus
    Kauke, Teresa
    CLINICAL TRANSPLANTATION, 2021, 35 (06)
  • [43] Everolimus-based immunosuppressive regimens in lung transplant recipients: Impact on CMV infection
    Ritta, Massimo
    Costa, Cristina
    Solidoro, Paolo
    Sidoti, Francesca
    Libertucci, Daniela
    Boffini, Massimo
    Rinaldi, Mauro
    Baldi, Sergio
    Cavallo, Rossana
    ANTIVIRAL RESEARCH, 2015, 113 : 19 - 26
  • [44] Late Onset Cytomegalovirus (CMV) Infection in Lung Transplant Recipients: Can CMV Serostatus Guide the Duration of Prophylaxis?
    Schoeppler, K. E.
    Zamora, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 48 - 48
  • [45] Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
    Johansson, Inger
    Martensson, Gunnar
    Nystrom, Ulla
    Nasic, Salmir
    Andersson, Rune
    BMC INFECTIOUS DISEASES, 2013, 13
  • [46] QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients
    Reusing, Jose O., Jr.
    Agena, Fabiana
    Kotton, Camille N.
    Campana, Gustavo
    Pierrotti, Ligia Camera
    David-Neto, Elias
    TRANSPLANTATION, 2024, 108 (04) : 985 - 995
  • [47] Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
    Inger Johansson
    Gunnar Mårtensson
    Ulla Nyström
    Salmir Nasic
    Rune Andersson
    BMC Infectious Diseases, 13
  • [48] Rolf of Cylex® assay in monitoring cytomegalovirus (CMV) infection or disease in lung transplant recipients
    Husain, S.
    Raza, K.
    McCurry, K. R.
    Pilewski, J.
    Spichty, K. J.
    Woodcock, J.
    Kowalski, R.
    Britz, J.
    Zeevi, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S164 - S164
  • [49] Cytomegalovirus Antibody Titers Correlate With the Risk of CMV Reactivation in CMV-Seropositive Liver Transplant Recipients
    Bruminhent, J.
    Thongprayoon, C.
    Razonable, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 179 - 179
  • [50] Cytomegalovirus (cmv) Infections In Heart And Lung Transplant Recipients
    Lee, S. J.
    Beam, E.
    Arguello, L. Y. Garcia
    Razonable, R. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345